TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis.

MLA

Marcel, V., et al. “TP53 PIN3 and MDM2 SNP309 Polymorphisms as Genetic Modifiers in the Li-Fraumeni Syndrome: Impact on Age at First Diagnosis.” Journal of Medical Genetics, vol. 46, no. 11, Nov. 2009, pp. 766–72. EBSCOhost, https://doi.org/10.1136/jmg.2009.066704.

APA

Marcel, V., Palmero, E. I., Falagan-Lotsch, P., Martel-Planche, G., Ashton-Prolla, P., Olivier, M., Brentani, R. R., Hainaut, P., & Achatz, M. I. (2009). TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. Journal of Medical Genetics, 46(11), 766–772. https://doi.org/10.1136/jmg.2009.066704

Chicago

Marcel, V, E I Palmero, P Falagan-Lotsch, G Martel-Planche, P Ashton-Prolla, M Olivier, R R Brentani, P Hainaut, and M I Achatz. 2009. “TP53 PIN3 and MDM2 SNP309 Polymorphisms as Genetic Modifiers in the Li-Fraumeni Syndrome: Impact on Age at First Diagnosis.” Journal of Medical Genetics 46 (11): 766–72. doi:10.1136/jmg.2009.066704.